News

"That’s when I started dreaming I could be a doctor someday, that I could get away, prescribe myself a new life."

Is there a unique, underrecognized psychological factor in the current dissemination of hate?

What is the best treatment course for prolonged grief disorder?

DaylightRx becomes the very first FDA-cleared digital treatment for generalized anxiety disorder.

MJH Life Sciences recently celebrated their 25th anniversary!

Abbott has initiated the TRANSCEND study to evaluate the use of deep brain stimulation to manage treatment-resistant depression.

What is the impact of current political events on the public's mental health?

A psychiatrist weighs in on the breaking news in Georgia, where there is yet another school shooting.

It is simply not the case that the DSM diagnostic categories are defined only by symptoms...

Phase 2 trials suggest extended-release oral ketamine formulations could be alternative to clinic-administered treatment for resistant depression.

Although the Model Curriculum for Teachers of Psychopharmacology has evolved over 2 decades, it continues to provide practical and easy to use resources for psychiatric educators from leading experts.

The impact of plastics on health is an area of increasing concern.

Write to us now to be part of our series on forensic psychiatry!

Fathers have to make psychological adjustments during their partner's pregnancy and during the first year with the baby. What does a meta-analysis tell us of their mental state?

Check out the new column, CREATIVE MINDS: Psychotherapeutic Approaches and Insights!

A psychiatrist pauses to reflect in awe...

Burnout rates have once again reached epidemic levels, in both physicians and parents.

Tomorrow, August 31, is Overdose Awareness Day. What can you be doing to help prevent overdose deaths?

Sleep and suicide? Researchers investigated improvement in insomnia as a pathway underlying the antisuicidal properties of clozapine.

"But before offering it to us over steamed rice, even before his gods, he’d serve those who were not home..."

What is new in research on major depressive disorder?

While new treatment options in the PTSD space can be exciting, we cannot lose sight of the treatments that are already readily available.

How can we tie politics, religion, and psychiatry into an organized project and work together to make a better world?

In this guest column, learn more about intensity, repetition, consistency, and integrity in rehabilitating neurological injury.

The first investigational, oral, muscarinic M4 selective agonist in development for the treatment of schizophrenia sees positive phase 2 results in the lowest tested dose.

Diagnostic criteria are not the same as the disorders they identify.

Diagnostic clarity between anhedonia and persistent depressive disorder is paramount in clinical practice to ensure effective and safe treatment for patients.

Group dynamics in band: can they illuminate greater truths for listeners?

If circular claims are presented together with unfounded claims about purported brain mechanisms, they may further bias individuals towards falsely assuming that biological causes and mechanisms have been identified for psychiatric problems.

A review and meta-analysis of antipsychotic dose-response literature prompts a proposal for lower maximum target doses.